It is a trading private limited company based in Sangli, Maharashtra, India, established in 2021.
2021 | Sangli, Maharashtra, India | ActiveIncorporeal Pharma Private Limited, a active private limited company, was established on 22 October 2021 in Sangli, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909PN2021PTC205424. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Sharad Aannaso Patil (Additional Director), Sachin Bhagwant Gondhale (Director), Aniket Sangameshwarkar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G3 ,Pranam Arcade, Kacchi Bhavan,Sangli, Sangli, Maharashtra, 416416.
U51909PN2021PTC205424
205424
22 October 2021
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Incorporeal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharad Aannaso Patil | Additional Director | 21 Aug 2023 | Current |
| Sachin Bhagwant Gondhale | Director | 22 Oct 2021 | Current |
| Aniket Sangameshwarkar | Director | 22 Oct 2021 | Current |
| Amit Ashok Shetti | Director | 22 Oct 2021 | Current |
| Jayshri Rajshekhar Hiremath | Additional Director | 27 Nov 2022 | Current |
| Dineshkumar Haribhau Dandekar | Additional Director | 06 Dec 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Incorporeal Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Incorporeal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Incorporeal Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Incorporeal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incorporeal Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Incorporeal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Incorporeal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
The activity Sharad Aannaso Patil was appointed as a Additional Director was appointed as a Additional Director on 21 Aug 2023 & has been associated with this company since 2 years 4 months . was completed.
The activity Dineshkumar Haribhau Dandekar was appointed as a Additional Director was appointed as a Additional Director on 06 Dec 2022 & has been associated with this company since 3 years 17 days . was completed.
Jayshri Rajshekhar Hiremath was appointed as a Additional Director was appointed as a Additional Director on 27 Nov 2022 & has been associated with this company since 3 years 26 days . was recorded as a recent event.
The activity Sachin Bhagwant Gondhale was appointed as a Director was appointed as a Director on 22 Oct 2021 & has been associated with this company since 4 years 2 months . was completed.
The CIN of Incorporeal Pharma Private Limited is U51909PN2021PTC205424.
Incorporeal Pharma Private Limited is headquartered at G3 ,Pranam Arcade, Kacchi Bhavan,Sangli, Sangli, Maharashtra, 416416.
Incorporeal Pharma Private Limited was incorporated on 22 October 2021.
The current directors of Incorporeal Pharma Private Limited are
The primary industry of Incorporeal Pharma Private Limited is Trading.
Incorporeal Pharma Private Limited is unlisted.
The authorized capital of Incorporeal Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX